{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:32:19Z","timestamp":1792225939603,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA256927"],"award-info":[{"award-number":["R01 CA256927"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Durable T cell immunity against cancer depends on the continual replenishment of effector CD8\u207a T cells. Thymic output has been associated with favorable prognosis in cancer patients across a range of ages, suggesting that the thymus is an important source for replenishing T cells capable of controlling cancer progression. However, whether CD8\u207a T cells acquire effector potential within the thymus, and how thymic output of effector CD8\u207a T cells contribute to peripheral tumor immunity, remain unclear. In this study, we discover that thymic single-positive (SP) CD8\u207a T cells undergo latent effector differentiation following thymic selection, but this process is subject to PD-1 regulation. We further demonstrate that PD-1 limits the contribution of thymic output of CD8\u207a T cells in shaping the TCR repertoire within the tumor tissues for tumor immunosurveillance. Although PD-1 inhibition facilitates the expansion of effector CD8\u207a T cells in the periphery, these cells gradually lose antitumor activity within tumors due to accelerated exhaustion in the absence of PD-1. Thus, while latent effector differentiation of thymic CD8\u207a T cells enables a rapid response to malignant cells in the periphery, PD-1 restrains this process to prevent overt or terminal effector differentiation, which may compromise balanced and durable peripheral immunity.<\/jats:p>","DOI":"10.1038\/s41467-026-73392-7","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:37:57Z","timestamp":1779525477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-9575","authenticated-orcid":false,"given":"Zhiming","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob B.","family":"Hirdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanina K.","family":"Gicobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Maynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-2607","authenticated-orcid":false,"given":"Michelle A.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia R.","family":"Dellacecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-5859","authenticated-orcid":false,"given":"Jacob J.","family":"Teske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey Y.","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0610-2321","authenticated-orcid":false,"given":"Geoffrey","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-9923","authenticated-orcid":false,"given":"Adrian T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9978-341X","authenticated-orcid":false,"given":"Virginia M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-345X","authenticated-orcid":false,"given":"Fabrice","family":"Lucien-Matteoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-3326","authenticated-orcid":false,"given":"Henrique","family":"Borges da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-9547","authenticated-orcid":false,"given":"Daniel D.","family":"Billadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5782-2983","authenticated-orcid":false,"given":"Haidong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"73392_CR1","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"73392_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2302892","volume":"389","author":"KA Kooshesh","year":"2023","unstructured":"Kooshesh, K. A., Foy, B. H., Sykes, D. B., Gustafsson, K. & Scadden, D. T. Health consequences of thymus removal in adults. New Engl. J. Med. 389, 406\u2013417 (2023).","journal-title":"New Engl. J. Med."},{"key":"73392_CR3","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.immuni.2024.08.019","volume":"57","author":"P Bohacova","year":"2024","unstructured":"Bohacova, P. et al. Multidimensional profiling of human T cells reveals high CD38 expression, marking recent thymic emigrants and age-related naive T cell remodeling. Immunity 57, 2362\u20132379 (2024).","journal-title":"Immunity"},{"key":"73392_CR4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/s41590-023-01584-0","volume":"24","author":"Z Steier","year":"2023","unstructured":"Steier, Z. et al. Single-cell multiomic analysis of thymocyte development reveals drivers of CD4+ T cell and CD8+ T cell lineage commitment. Nat. Immunol. 24, 1579\u20131590 (2023).","journal-title":"Nat. Immunol."},{"key":"73392_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41577-023-00911-8","volume":"24","author":"KM Ashby","year":"2023","unstructured":"Ashby, K. M. & Hogquist, K. A. A guide to thymic selection of T cells. Nat. Rev. Immunol. 24, 103\u2013117 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"73392_CR6","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. New Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"New Engl. J. Med."},{"key":"73392_CR7","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","volume":"124","author":"A Gros","year":"2014","unstructured":"Gros, A. et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J. Clin. Investig. 124, 2246\u20132259 (2014).","journal-title":"J. Clin. Investig."},{"key":"73392_CR8","doi-asserted-by":"crossref","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv4 (2016).","DOI":"10.1126\/scitranslmed.aad7118"},{"key":"73392_CR9","doi-asserted-by":"crossref","unstructured":"Vesely, M. D., Zhang, T. & Chen, L. Resistance mechanisms to anti-PD cancer immunotherapy. Annu. Rev. Immunol. 40, 45\u201374 (2022).","DOI":"10.1146\/annurev-immunol-070621-030155"},{"key":"73392_CR10","doi-asserted-by":"crossref","unstructured":"Yang, X. & Chen, L. Why has immune \u2018checkpoint\u2019 therapy failed in most clinical trials? J. Immunother. Cancer 13, e012457 (2025).","DOI":"10.1136\/jitc-2025-012457"},{"key":"73392_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73392_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265\u2013276 (2015).","journal-title":"Trends Immunol."},{"key":"73392_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity 51, 1043\u20131058 (2019).","journal-title":"Immunity"},{"key":"73392_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1084\/jem.191.5.891","volume":"191","author":"H Nishimura","year":"2000","unstructured":"Nishimura, H., Honjo, T. & Minato, N. Facilitation of \u03b2 selection and modification of positive selection in the thymus of Pd-1-deficient mice. J. Exp. Med. 191, 891\u2013898 (2000).","journal-title":"J. Exp. Med."},{"key":"73392_CR15","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.4049\/jimmunol.175.11.7372","volume":"175","author":"ME Keir","year":"2005","unstructured":"Keir, M. E., Latchman, Y. E., Freeman, G. J. & Sharpe, A. H. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol. 175, 7372\u20137379 (2005).","journal-title":"J. Immunol."},{"key":"73392_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adh2456","volume":"16","author":"N Paillon","year":"2024","unstructured":"Paillon, N. et al. PD-1 inhibits T cell actin remodeling at the immunological synapse independently of its signaling motifs. Sci. Signal. 16, eadh2456 (2024).","journal-title":"Sci. Signal."},{"key":"73392_CR17","doi-asserted-by":"crossref","unstructured":"Maurice, N. J., Berner, J., Taber, A. K., Zehn, D. & Prlic, M. Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells. JCI Insight 6, e150744 (2021).","DOI":"10.1172\/jci.insight.150744"},{"key":"73392_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nprot.2014.005","volume":"9","author":"KG Anderson","year":"2014","unstructured":"Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209\u2013222 (2014).","journal-title":"Nat. Protoc."},{"key":"73392_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4049\/jimmunol.1501050","volume":"195","author":"KA Hogquist","year":"2015","unstructured":"Hogquist, K. A., Xing, Y., Hsu, F.-C. & Shapiro, V. S. T cell adolescence: maturation events beyond positive selection. J. Immunol. 195, 1351\u20131357 (2015).","journal-title":"J. Immunol."},{"key":"73392_CR20","doi-asserted-by":"publisher","unstructured":"Hsu, F.-C. et al. Immature recent thymic emigrants are eliminated by complement 1. https:\/\/doi.org\/10.4049\/jimmunol.1401871.","DOI":"10.4049\/jimmunol.1401871"},{"key":"73392_CR21","doi-asserted-by":"crossref","unstructured":"Nelson, N. et al. A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity. Oncoimmunology 8, 1599635 (2019).","DOI":"10.1080\/2162402X.2019.1599635"},{"key":"73392_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4161\/onci.20850","volume":"1","author":"RM Gibbons","year":"2012","unstructured":"Gibbons, R. M. et al. B7-H1 limits the entry of effector CD8+ T cells to the memory pool by upregulating bim. Oncoimmunology 1, 1061\u20131073 (2012).","journal-title":"Oncoimmunology"},{"key":"73392_CR23","doi-asserted-by":"crossref","unstructured":"Pauken, K. E. et al. PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion. J. Exp. Med. 222, e20230542 (2025).","DOI":"10.1084\/jem.20230542"},{"key":"73392_CR24","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Endogenous tumor-reactive CD8+ T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth. Oncoimmunology 2, e23972 (2013).","DOI":"10.4161\/onci.23972"},{"key":"73392_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"73392_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"73392_CR27","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1126\/sciimmunol.ado3032","volume":"10","author":"YJ Huang","year":"2025","unstructured":"Huang, Y. J. et al. Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate. Sci. Immunol. 10, 3032 (2025).","journal-title":"Sci. Immunol."},{"key":"73392_CR28","doi-asserted-by":"publisher","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. https:\/\/doi.org\/10.1038\/s41467-021-23324-4 (2021).","DOI":"10.1038\/s41467-021-23324-4"},{"key":"73392_CR29","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1158\/2326-6066.CIR-25-0384","volume":"13","author":"H Dong","year":"2025","unstructured":"Dong, H. et al. A dual role for NKG7 in T-cell cytotoxicity and longevity. Cancer Immunol. Res. 13, 1510\u20131515 (2025).","journal-title":"Cancer Immunol. Res."},{"key":"73392_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nm.3860","volume":"21","author":"O Gaide","year":"2015","unstructured":"Gaide, O. et al. Common clonal origin of central and resident memory T cells following skin immunization. Nat. Med. 21, 647\u2013653 (2015).","journal-title":"Nat. Med."},{"key":"73392_CR31","doi-asserted-by":"crossref","unstructured":"Kuwata, N., Igarashi, H., Ohmura, T., Aizawa, S. & Sakaguchi, N. Cutting edge: absence of expression of RAG1 in peritoneal B-1 cells detected by knocking into RAG1 locus with green fluorescent protein gene1. https:\/\/academic.oup.com\/jimmunol\/article\/163\/12\/6355\/8040137 (1999).","DOI":"10.4049\/jimmunol.163.12.6355"},{"key":"73392_CR32","first-page":"1","volume":"15","author":"D Masopust","year":"2025","unstructured":"Masopust, D. et al. Guidelines for T cell nomenclature. Nat. Rev. Immunol. 15, 1\u201316 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"73392_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cell.2018.05.029","volume":"174","author":"NL Smith","year":"2018","unstructured":"Smith, N. L. et al. Developmental origin governs CD8+ T cell fate decisions during infection. Cell 174, 117\u2013130 (2018).","journal-title":"Cell"},{"key":"73392_CR34","doi-asserted-by":"publisher","unstructured":"Hor, J. L. et al. Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells. Nature 1\u201311, https:\/\/doi.org\/10.1038\/s41586-025-09440-x (2025).","DOI":"10.1038\/s41586-025-09440-x"},{"key":"73392_CR35","doi-asserted-by":"publisher","unstructured":"Chopp, L. B. et al. An integrated epigenomic and transcriptomic map of mouse and human \u03b1\u03b2 T cell development. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.024 (2020).","DOI":"10.1016\/j.immuni.2020.10.024"},{"key":"73392_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20142237","volume":"212","author":"PM Odorizzi","year":"2015","unstructured":"Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A. & John Wherry, E. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J. Exp. Med. 212, 1125\u20131137 (2015).","journal-title":"J. Exp. Med."},{"key":"73392_CR37","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1126\/sciimmunol.aay1863","volume":"5","author":"L Strauss","year":"2020","unstructured":"Strauss, L. et al. Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. Sci. Immunol. 5, 1863 (2020).","journal-title":"Sci. Immunol."},{"key":"73392_CR38","doi-asserted-by":"crossref","unstructured":"Ham, H. et al. Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control. Nat. Commun. 16, 1628 (2025).","DOI":"10.1038\/s41467-025-56931-6"},{"key":"73392_CR39","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"73392_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"73392_CR41","doi-asserted-by":"publisher","first-page":"853003","DOI":"10.3389\/fcell.2022.853003","volume":"10","author":"L Ding","year":"2022","unstructured":"Ding, L. et al. Nuclear GSK-3\u03b2 and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN. Front. Cell Dev. Biol. 10, 853003 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"73392_CR42","doi-asserted-by":"crossref","unstructured":"Mao, Z. et al. PD-1 prelimits both cytotoxic and exhaustion potential in thymic CD8+ T cells and affects sustaining peripheral tumor immunity. J. Immunol. 214, 2875 (2025).","DOI":"10.1093\/jimmun\/vkaf283.744"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73392-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:01:56Z","timestamp":1784635316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73392-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73392"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73392-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B.d.S. is an advisor for the International Genomics Consortium. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6769"}}